On Sept. 29, a three-judge panel on the District of Columbia’s appeals court decided that “through their product placement practices, Walmart and CVS mislead consumers into believing that homeopathic products are equivalent alternatives to FDA-approved over-the-counter drugs.”
The Center for Inquiry filed the two lawsuits citing the Consumer Protection Procedures Act in 2018 and 2019, but lower courts said CFI couldn’t bring suits on behalf of consumers because the nonprofit organization isn’t a consumer protection organization. The appeals court amended that statement to qualify CFI as a consumer protection organization.
“The Court of Appeals rightly recognized that giant retailers can’t just deny responsibility for how they present what are fundamentally worthless products,” Nick Little, CFI’s legal director, said in a news release.
CVS did not immediately respond to Becker’s requests for comment, but a Walmart spokesperson said the company disagrees with the decision.
“We are continuing to review the Court’s decision and are weighing our options for further appellate review,” Walmart spokesperson Abby Williams-Bailey said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
